## Gene Summary
MC4R, or Melanocortin 4 Receptor, is a key regulator of energy homeostasis and appetite control in the human body. This receptor belongs to the G protein-coupled receptor family and is expressed predominantly in the central nervous system, particularly within the hypothalamus. MC4R plays a critical role in the regulation of food intake and body weight by mediating the effects of melanocortin peptides such as Î±-melanocyte-stimulating hormone, which are derived from proopiomelanocortin (POMC). Variations in the function of this receptor can significantly impact metabolic processes and are linked to obesity.

## Gene Drugs, Diseases, Phenotypes, and Pathways
MC4R is closely associated with several phenotypes mainly concerning obesity and related metabolic disorders. Due to its pivotal role in energy balance, mutations or dysregulation of MC4R can lead to severe early-onset obesity and are often associated with increased appetite and reduced satiety. Other linked conditions may include increased insulin resistance and altered lipid metabolism. The MC4R pathway involves signaling through the melanocortin pathway which has downstream effects on appetite regulation and energy expenditure.

## Pharmacogenetics
The pharmacogenetics of MC4R is particularly relevant in the context of treatments for obesity. Variants of MC4R can influence the efficacy and response to certain medications aimed at weight management and appetite control. For instance, setmelanotide, a melanocortin 4 receptor agonist, has been developed to target this pathway and is used particularly for obesity cases attributed to certain genetic deficits involving MC4R. The effectiveness of such treatments can vary significantly depending on the specific MC4R mutations present in an individual, highlighting the importance of genetic testing in personalized medicine for obesity and metabolic disorders.